Interne link ProQR spins out Amylon Therapeutics as a privately-held company focused on central nervous system (CNS) therapeutics september 12, 2017 om 11:00 AM UTC
Interne link ProQR’s Drug Candidate QRX-421 for Usher Syndrome Receives Orphan Drug Designation from FDA and EMA september 05, 2017 om 11:00 AM UTC
Interne link ProQR Completes Dosing of Cystic Fibrosis Patients in QR-010 Phase 1b Trial augustus 29, 2017 om 11:00 AM UTC
Interne link ProQR Strengthens its Scientific Advisory Board with the Appointment of Dr. Phil Zamore, Dr. Cy Stein and Dr. Scott Armstrong augustus 28, 2017 om 11:00 AM UTC
Interne link ProQR Announces Results for the Second Quarter of 2017 augustus 16, 2017 om 11:00 AM UTC
Interne link ProQR’s Drug Candidate QRX-411 for Usher Syndrome Receives Orphan Drug Designation from FDA and EMA juli 05, 2017 om 11:00 AM UTC
Interne link ProQR R&D day Highlights Progress on Pipeline and Introduces Axiomer®, a novel proprietary RNA Technology juni 15, 2017 om 11:04 AM UTC
Interne link ProQR to Participate in a Cystic Fibrosis Panel Discussion during the JMP Securities Life Science Conference juni 13, 2017 om 11:00 AM UTC
Interne link ProQR to present QR-010 data at the European Cystic Fibrosis Society Conference and provides an update on the ongoing Phase 1b trial juni 08, 2017 om 01:03 PM UTC
Interne link ProQR Receives Fast Track Designation from the FDA for QR-110 for Leber’s Congenital Amaurosis Type 10 mei 31, 2017 om 11:00 AM UTC
Interne link ProQR remembers co-founder Henri Termeer after his unexpected passing mei 15, 2017 om 11:00 AM UTC
Interne link ProQR to Present its Ophthalmology Pipeline at ARVO, Highlighting Programs in Leber’s Congenital Amaurosis Type 10 (LCA 10) and Usher Syndrome mei 01, 2017 om 11:00 AM UTC
Interne link ProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 Patients april 27, 2017 om 11:00 AM UTC
Interne link ProQR to Present at the Deutsche Bank Health Care Conference april 20, 2017 om 11:00 AM UTC
Interne link ProQR Announces the Grant of two Key Patents, protecting QR-010 for Cystic Fibrosis in the US and EU april 03, 2017 om 11:00 AM UTC
Interne link ProQR Appoints David M. Rodman, MD as Chief Development Strategy Officer maart 27, 2017 om 11:00 AM UTC
Interne link ProQR to Present at Two Upcoming Investor Conferences in March maart 01, 2017 om 12:00 PM UTC
Interne link ProQR Announces Results for the Fourth Quarter and Full Year 2016 and Provides a Business Update februari 28, 2017 om 12:00 PM UTC
Interne link On a Shared Quest to Find Treatments for Rare Diseases, ProQR Supports Rare Disease Day februari 27, 2017 om 12:00 PM UTC
Interne link ProQR to Present at the LEERINK Partners Global Healthcare Conference februari 07, 2017 om 12:00 PM UTC
Interne link ProQR Announces that QR-010 Meets the Primary Endpoint in a Proof of Concept Study of Homozygous F508del Cystic Fibrosis Patients oktober 27, 2016 om 11:00 AM UTC